4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-010473
CHIEF FINANCIAL OFFICER sold 118,477 shares at an average $39.58 ($4,689,722)
- CHIEF FINANCIAL OFFICER acquired 99,828 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Grant Sean · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-03 | Exercise or conversion : show line 1 in the form | +99,828 | $14.87 | $1,484,442 | 166,165 | D |
| 2024-04-03 | Sale : show line 2 in the form | −69,831 | $40.05 | $2,796,801 | 96,334 | D |
| 2024-04-03 | Sale : show line 3 in the form | −10,988 | $38.65 | $424,708 | 85,346 | D |
| 2024-04-03 | Sale : show line 4 in the form | −11,648 | $38.13 | $444,080 | 73,698 | D |
| 2024-04-03 | Sale : show line 5 in the form | −7,361 | $39.25 | $288,927 | 66,337 | D |
| 2024-04-03 | Sale : show line 6 in the form | −78 | $38.20 | $2,979 | 257 | I |
| 2024-04-03 | Sale : show line 7 in the form | −80 | $39.22 | $3,137 | 177 | I |
| 2024-04-03 | Sale : show line 8 in the form | −177 | $40.06 | $7,090 | 0 | I |
| Open-market sales · 118,477 sh · avg $39.58 · $4,689,722 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-03 | Exercise or conversion : show line 21 in the form Stock Option (right to buy) | −99,828 | 80,172 | D |
Loading xslF345X05/form4-04062024_010405.xml…